Abstract
The World Health Organization (WHO) reported that by 2030, diabetes mellitus would become the 7th leading cause of death. Diabetes mellitus is a chronic disease that causes various complications, one of which is peripheral neuropathy. Preventive efforts for peripheral neuropathy involve conducting detection examinations. The purpose of this study was to analyze nerve damage in peripheral neuropathy cases using the MNSI (Michigan Neuropathy Screening Instrument) and MDNS (Michigan Diabetic Neuropathy Score) instruments. The study employed a cross-sectional study approach with a sample of 50 people, using total sampling as the sampling technique. The independent variable in this study was nerve damage, and the dependent variable was peripheral neuropathy. Data collection in the study was carried out using the MNSI and MDNS instruments to link the dependent and independent variables. Hypothesis analysis in this study was conducted using the Spearman's rho correlation test. The study found that autonomic, sensory, and motor damage correlated with peripheral neuropathy, with a P-value of < 0.05. Examinations in the feet of diabetics were significantly related to the level of peripheral neuropathy. However, there was no evidence of a correlation between the characteristics of the respondents and the incidence of peripheral neuropathy. The results of the nerve damage examination demonstrated a correlation between different types of damage, and the MNSI and MDNS instruments proved effective in detecting peripheral neuropathy damage. Future research should focus on more in-depth studies to explore the correlation of nerve damage in patients with diabetes mellitus detected at a young age and consider other variables, such as HbA1c levels, as potential risk factors for peripheral neuropathy.
Subject
Industrial and Manufacturing Engineering,Environmental Engineering
Reference57 articles.
1. Mboi N, Syailendrawati R, Ostroff SM, Elyazar IR, Glenn SD, Rachmawati T, et al. The state of health in Indonesia’s provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2022;10(11):e1632–45.
2. Adi Pamungkas R, Mayasari Usman A. Panduan Praktis Screening Resiko Diabetes dan Neuropathy . Listiyawati I, Rosyidi K, editors. Vol. Pertama. Bondowoso: KHD Production ; 2021.
3. Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun 13;5(1):41.
4. Oliveira-Abreu K, Cipolla-Neto J, Leal-Cardoso JH. Effects of Melatonin on Diabetic Neuropathy and Retinopathy. Int J Mol Sci. 2021 Dec 22;23(1):100.
5. Dixit S, Maiya A. Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review. J Postgrad Med. 2014;60(1):33–40.